| [1] |
Millard NE, De Braganca KC. Medulloblastoma[J]. J Child Neurol, 2016, 31(12): 1341-1353.
|
| [2] |
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007, 114(2): 97-109.
|
| [3] |
Das U, Appaji L, Kumari BS, et al. Spectrum of pediatric brain tumors: a report of 341 cases from a tertiary cancer center in India[J]. Indian J Pediatr, 2014, 81(10): 1089-1091.
|
| [4] |
Chan AW, Tarbell NJ, Black PM, et al. Adult medulloblastoma: prognostic factors and patterns of relapse[J]. Neurosurgery, 2000, 47(3): 623-631; discussion 631-622.
|
| [5] |
Khalil J, Chaabi S, Oberlin O, et al. Medulloblastoma in childhood: what effects on neurocognitive functions?[J]. Cancer Radiother, 2019, 23(5): 370-377.
|
| [6] |
Bokun J, Grujicic D, Skender-Gazibara M, et al. Management and treatment of children with medulloblastoma in serbia, a middle-income country[J]. J BUON, 2018, 23(4): 1156-1162.
|
| [7] |
孔垂广，白威，叶玉勤,等.小儿神经外科疾病的单中心研究[J].中华神经外科杂志, 2019, 35(12): 1231-1235.
|
| [8] |
Alexiou GA, Moschovi M, Stefanaki K, et al. Epidemiology of pediatric brain tumors in Greece (1991-2008). Experience from the Agia Sofia children’s hospital[J]. Cent Eur Neurosurg, 2011, 72(1): 1-4.
|
| [9] |
Bartlett F, Kortmann R, Saran F. Medulloblastoma[J]. Clin Oncol (R Coll Radiol), 2013, 25(1): 36-45.
|
| [10] |
Hovestadt V, Ayrault O, Swartling FJ, et al. Medulloblastomics revisited: biological and clinical insights from thousands of patients[J]. Nat Rev Cancer, 2020, 20(1): 42-56.
|
| [11] |
Massimino M, Biassoni V, Gandola L, et al. Childhood medulloblastoma[J]. Crit Rev Oncol Hematol, 2016, 105: 35-51.
|
| [12] |
Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma[J]. J Clin Oncol, 2006, 24(25): 4202-4208.
|
| [13] |
Mathew RK, O’Kane R, Parslow R, et al. Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors[J]. Neuro Oncol, 2014, 16(8): 1137-1145.
|
| [14] |
Wang C, Yuan XJ, Jiang MW, et al. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma[J]. J Neurosurg Pediatr, 2016, 17(1): 49-56.
|
| [15] |
Padovani L, Sunyach MP, Perol D, et al. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults[J]. Int J Radiat Oncol Biol Phys, 2007, 68(2): 433-440.
|
| [16] |
Yu J, Zhao R, Shi W, et al. Risk factors for the prognosis of pediatric medulloblastoma: a retrospective analysis of 40 cases[J]. Clinics(Sao Paulo), 2017, 72(5): 294-304.
|
| [17] |
Jiang T, Zhang Y, Wang J, et al. Impact of tumor location and fourth ventricle infiltration in medulloblastoma[J]. Acta Neurochir(Wien), 2016, 158(6): 1187-1195.
|
| [18] |
von Bueren AO, von Hoff K, Pietsch T, et al. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology[J]. Neuro Oncol, 2011, 13(6): 669-679.
|
| [19] |
Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas[J]. Radiology, 1969, 93(6): 1351-1359.
|
| [20] |
Bowers DC, Gargan L, Weprin BE, et al. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma[J]. J Neurosurg, 2007, 107(1 Suppl): 5-10.
|
| [21] |
Dufour C, Beaugrand A, Pizer B, et al. Metastatic medulloblastoma in childhood: Chang’s classification revisited[J]. Int J Surg Oncol, 2012, 2012: 245385.
|
| [22] |
Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the children’s cancer group 921 randomized phase III study[J]. J Clin Oncol, 1999, 17(3): 832-845.
|
| [23] |
Pogorzala M, Styczynski J, Wysocki M. Survival and prognostic factors in children with brain tumors: long-term follow-up single center study in Poland[J]. Anticancer Res, 2014, 34(1): 323-326.
|
| [24] |
Thompson EM, Hielscher T, Bouffet E, et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis[J]. Lancet Oncol, 2016, 17(4): 484-495.
|
| [25] |
Atallah A, Rady MR, Kamal HM, et al. Telovelar approach to pediatric fourth ventricle tumors: feasibility and outcome[J]. Turk Neurosurg, 2019, 29(4): 497-505.
|
| [26] |
Rutkowski S, von Hoff K, Emser A, et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis[J]. J Clin Oncol, 2010, 28(33): 4961-4968.
|
| [27] |
Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study[J]. Lancet Oncol, 2014, 15(1): 35-47.
|
| [28] |
Ramaswamy V, Remke M, Bouffet E, et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis[J]. Lancet Oncol, 2013, 14(12): 1200-1207.
|
| [29] |
Ramaswamy V, Remke M, Bouffet E, et al. Risk stratification of childhood medulloblastoma in the molecular era: The current consensus[J]. Acta Neuropathol, 2016, 131(6): 821-831.
|
| [30] |
Khatua S, Zaky W. The biologic era of childhood medulloblastoma and clues to novel therapies[J]. Future Oncol, 2014, 10(4): 637-645.
|